Literature DB >> 15503153

Parkin-associated Parkinson's disease.

Rainer von Coelln1, Valina L Dawson, Ted M Dawson.   

Abstract

Mutations in the PARK2 gene coding for parkin cause autosomal recessive juvenile parkinsonism (AR-JP), a familial form of Parkinson's disease (PD). Parkin functions as an E3 ubiquitin ligase, and loss of this ubiquitin ligase activity appears to be the mechanism underlying pathogenesis of AR-JP. Recently, the spectrum of genetic, clinical, and pathological findings on AR-JP has been significantly expanded. Moreover, a considerable number of parkin interactors and/or substrates have been identified and characterized, and animal models of parkin deficiency have been generated. In this review, we provide an overview of the most relevant findings and discuss their implications for the pathogenesis of AR-JP and sporadic PD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15503153     DOI: 10.1007/s00441-004-0924-4

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  38 in total

1.  CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome.

Authors:  Regina Groisman; Isao Kuraoka; Odile Chevallier; Nogaye Gaye; Thierry Magnaldo; Kiyoji Tanaka; Alexei F Kisselev; Annick Harel-Bellan; Yoshihiro Nakatani
Journal:  Genes Dev       Date:  2006-06-01       Impact factor: 11.361

Review 2.  Aggresome formation and neurodegenerative diseases: therapeutic implications.

Authors:  J A Olzmann; L Li; L S Chin
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 3.  Redox proteomics in some age-related neurodegenerative disorders or models thereof.

Authors:  D Allan Butterfield; Hafiz Mohmmad Abdul; Shelley Newman; Tanea Reed
Journal:  NeuroRx       Date:  2006-07

Review 4.  Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes.

Authors:  Laura Scott; Valina L Dawson; Ted M Dawson
Journal:  Exp Neurol       Date:  2017-04-23       Impact factor: 5.330

5.  Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease.

Authors:  Syed Z Imam; Qing Zhou; Ayako Yamamoto; Anthony J Valente; Syed F Ali; Mona Bains; James L Roberts; Philipp J Kahle; Robert A Clark; Senlin Li
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

6.  Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.

Authors:  Asad A Aboud; Andrew M Tidball; Kevin K Kumar; M Diana Neely; Kevin C Ess; Keith M Erikson; Aaron B Bowman
Journal:  Neurotoxicology       Date:  2012-10-22       Impact factor: 4.294

7.  Identification and characterization of a novel endogenous murine parkin mutation.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

8.  KF-1 Ubiquitin Ligase: An Anxiety Suppressor.

Authors:  Tamotsu Hashimoto-Gotoh; Naoyuki Iwabe; Atsushi Tsujimura; Keizo Takao; Tsuyoshi Miyakawa
Journal:  Front Neurosci       Date:  2009-05-01       Impact factor: 4.677

9.  Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.

Authors:  Kenneth M Rosen; Charbel E-H Moussa; Han-Kyu Lee; Pravir Kumar; Tohru Kitada; Gangjian Qin; Qinghao Fu; Henry W Querfurth
Journal:  J Neurosci Res       Date:  2010-01       Impact factor: 4.164

10.  DNA damage induces nuclear translocation of parkin.

Authors:  Shyan-Yuan Kao
Journal:  J Biomed Sci       Date:  2009-07-17       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.